Jiameng Zhang - Publications

Affiliations: 
2004 Biostatistics University of Pennsylvania, Philadelphia, PA, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Zhang J, Waubant E, Cutter G, Wolinsky J, Leppert D. Composite end points to assess delay of disability progression by MS treatments. Multiple Sclerosis Journal. 20: 1494-1501. PMID 24675040 DOI: 10.1177/1352458514527180  0.314
2013 Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R. EDSS variability before randomization may limit treatment discovery in primary progressive MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 775-81. PMID 23027880 DOI: 10.1177/1352458512459685  0.312
2012 Zhang J, Waubant E, Cutter G, Wolinsky J, Glanzman R. Improvements in the Power of Detecting Treatment Effect in a Primary Progressive Multiple Sclerosis (PPMS) Clinical Trial with the Use of Composite Disability Outcome Endpoints (P01.151) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.151  0.33
2009 Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Annals of Neurology. 66: 460-71. PMID 19847908 DOI: 10.1002/Ana.21867  0.318
2007 Zhang J, Heitjan DF. Impact of nonignorable coarsening on Bayesian inference. Biostatistics (Oxford, England). 8: 722-43. PMID 17215331 DOI: 10.1093/Biostatistics/Kxm001  0.501
2006 Zhang J, Heitjan DF. A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring. Biometrics. 62: 1260-8. PMID 17156301 DOI: 10.1111/J.1541-0420.2006.00580.X  0.492
2005 Zhang J, Heitjan DF. Nonignorable censoring in randomized clinical trials. Clinical Trials (London, England). 2: 488-96. PMID 16422309 DOI: 10.1191/1740774505Cn128Oa  0.475
Show low-probability matches.